Insider · CIK 0002046425
Jennifer Ann Nelson
Files at OMGA (Omega Therapeutics, Inc.). First filing -, latest -.
Jennifer Ann Nelson files SEC Form 4 as officer at OMGA (Omega Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jennifer Ann Nelson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | OMGA Omega Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Nov 26, 2024 |
Questions about Jennifer Ann Nelson
Answered from the filings on this page, as of the latest one.
Is Jennifer Ann Nelson buying or selling?
Jennifer Ann Nelson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jennifer Ann Nelson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Ann Nelson has 0.
Where does Jennifer Ann Nelson file Form 4?
Jennifer Ann Nelson has filed Form 4 at OMGA (Omega Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.